Share this article
Share this article
ABBOTT PARK, Ill., April 8, 2021 /PRNewswire/ Abbott (NYSE: ABT) today announced it has received CE Mark for its next-generation TriClip™ Transcatheter Tricuspid Valve Repair System, the first-of-its-kind minimally invasive tricuspid heart valve repair device available in Europe to treat tricuspid regurgitation (TR). The clip-based therapy, known as TriClip G4, is a non-surgical heart valve repair option specifically designed for the treatment of TR, or a leaky tricuspid valve, that allows physicians to tailor repair of the valve to each patient s unique anatomy.
Often referred to as the forgotten valve because of historically limited treatment options, the tricuspid valve has three leaflets that control the flow of blood between the two chambers on the right side of the heart (right ventricle and right atrium). When those leaflets do not close properly, blood can flow in the reverse direction – known as regurgitation – forcing the
Abbott Receives CE Mark Approval for Next-Generation TriClip Device, Offering New Innovations for Tricuspid Heart Valve Repair
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
Voltaremos a nos abraçar após a pandemia?
globo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globo.com Daily Mail and Mail on Sunday newspapers.
Western-educated professor who advocated classics
archive.shine.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.shine.cn Daily Mail and Mail on Sunday newspapers.
9 out of 10 dental injuries not reported on full-body trauma CTs
drbicuspid.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from drbicuspid.com Daily Mail and Mail on Sunday newspapers.